全文获取类型
收费全文 | 22706篇 |
免费 | 2656篇 |
国内免费 | 588篇 |
专业分类
耳鼻咽喉 | 217篇 |
儿科学 | 478篇 |
妇产科学 | 664篇 |
基础医学 | 2444篇 |
口腔科学 | 439篇 |
临床医学 | 3740篇 |
内科学 | 3924篇 |
皮肤病学 | 481篇 |
神经病学 | 1459篇 |
特种医学 | 842篇 |
外国民族医学 | 14篇 |
外科学 | 2907篇 |
综合类 | 1979篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 1476篇 |
眼科学 | 551篇 |
药学 | 1903篇 |
14篇 | |
中国医学 | 625篇 |
肿瘤学 | 1788篇 |
出版年
2024年 | 62篇 |
2023年 | 296篇 |
2022年 | 572篇 |
2021年 | 891篇 |
2020年 | 682篇 |
2019年 | 697篇 |
2018年 | 817篇 |
2017年 | 702篇 |
2016年 | 798篇 |
2015年 | 983篇 |
2014年 | 1137篇 |
2013年 | 1166篇 |
2012年 | 1577篇 |
2011年 | 1544篇 |
2010年 | 1204篇 |
2009年 | 904篇 |
2008年 | 1176篇 |
2007年 | 1237篇 |
2006年 | 1153篇 |
2005年 | 994篇 |
2004年 | 852篇 |
2003年 | 754篇 |
2002年 | 638篇 |
2001年 | 503篇 |
2000年 | 477篇 |
1999年 | 436篇 |
1998年 | 254篇 |
1997年 | 266篇 |
1996年 | 222篇 |
1995年 | 194篇 |
1994年 | 182篇 |
1993年 | 148篇 |
1992年 | 245篇 |
1991年 | 219篇 |
1990年 | 244篇 |
1989年 | 194篇 |
1988年 | 205篇 |
1987年 | 172篇 |
1986年 | 173篇 |
1985年 | 142篇 |
1984年 | 102篇 |
1983年 | 90篇 |
1982年 | 70篇 |
1981年 | 58篇 |
1980年 | 40篇 |
1979年 | 47篇 |
1978年 | 38篇 |
1975年 | 41篇 |
1974年 | 41篇 |
1973年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
Guochuan Tsai Hsien-Yuan Lane Pinchen Yang Mian-Yoon Chong Nicholas Lange 《Neuropsychopharmacology》2004,55(5):452-456
BACKGROUND: Hypofunction of N-methyl-D-aspartate glutamate receptor had been implicated in the pathophysiology of schizophrenia. Treatment with D-serine or glycine, endogenous full agonists of the glycine site of N-methyl-D-aspartate receptor, or D-cycloserine, a partial agonist, improve the symptoms of schizophrenia. N-methylglycine (sarcosine) is an endogenous antagonist of glycine transporter-1, which potentiates glycine's action on N-methyl-D-aspartate glycine site and can have beneficial effects on schizophrenia. METHODS: Thirty-eight schizophrenic patients were enrolled in a 6-week double-blind, placebo-controlled trial of sarcosine (2 g/d), which was added to their stable antipsychotic regimens. Twenty of them received risperidone. Measures of clinical efficacy and side effects were determined every other week. RESULTS: Patient who received sarcosine treatment revealed significant improvements in their positive, negative, cognitive, and general psychiatric symptoms. Similar therapeutic effects were observed when only risperidone-treated patients were analyzed. Sarcosine was well-tolerated, and no significant side effect was noted. CONCLUSIONS: Sarcosine treatment can benefit schizophrenic patients treated by antipsychotics including risperidone. The significant improvement with the sarcosine further supports the hypothesis of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Glycine transporter-1 is a novel target for the pharmacotherapy to enhance N-methyl-D-aspartate function. 相似文献
52.
53.
54.
Feng-Yuan Liu Chien-Yu Lin Joseph T Chang Shu-Hang Ng Shy-Chyi Chin Hung-Ming Wang Chun-Ta Liao Sheng-Chieh Chan Tzu-Chen Yen 《Journal of nuclear medicine》2007,48(10):1614-1619
Conventional work-up (CWU) with chest radiography, abdominal ultrasonography, and skeletal scintigraphy has limited value in M staging of nonkeratinizing nasopharyngeal carcinoma (NPC). Our aim was to evaluate whether (18)F-FDG PET could replace CWU by comparing their diagnostic efficacies. METHODS: Patients with histologically proven nonkeratinizing NPC and no prior treatment were prospectively enrolled. All study participants underwent CWU and (18)F-FDG PET for primary M staging. Distant metastasis was considered to be present if there was any reliable evidence identified within 1 y after diagnosis. The comparative diagnostic efficacies of (18)F-FDG PET, CWU, and the combination of (18)F-FDG PET and CWU (PET+CWU) were evaluated using the areas under the receiver-operating-characteristic (ROC) curves. RESULTS: Sixty-one (20.3%) of 300 eligible patients were found to have distant metastases. On a patient-based analysis, (18)F-FDG PET was found to be more effective than CWU (P < 0.001), whereas it was equally effective with PET+CWU (P = 0.130). On region-based analyses, (18)F-FDG PET was more effective than skeletal scintigraphy and chest radiography for detecting bone metastases (P < 0.001) and chest metastases (P < 0.001), respectively. (18)F-FDG PET and abdominal ultrasound were equally effective for detecting hepatic metastases (P = 0.127). On region-based analyses, the combination of (18)F-FDG PET and CWU did not yield any noticeable increase in diagnostic efficacy. CONCLUSION: (18)F-FDG PET can replace CWU in primary M staging of nonkeratinizing NPC. 相似文献
55.
56.
57.
58.
Sandrine Souverain Chin Eap Jean-Luc Veuthey Serge Rudaz 《Clinical chemistry and laboratory medicine》2003,41(12):1615-1621
Methadone (MTD) is a chiral drug widely used for the treatment of opioid dependence for which a rapid analytical method for the determination of each enantiomer would be advantageous. In order to improve method sensitivity and to automate the entire analytical process, a column-switching configuration has been developed. An online extraction system coupled to a cellulose-based chiral stationary phase (CSP), namely Chiralcel OJ-R, was used and detection was performed by mass spectrometry. Fifty microl of plasma were injected into the liquid chromatography-mass spectrometry (LC-MS) system after addition of acetonitrile (ACN) containing methadone deuterated D9 (MTD-D9) (internal standard) and centrifugation. For the rapid extraction step, a large particle size support was selected. A baseline separation of MTD enantiomers was obtained in less than 12 min. Trueness and precision were evaluated with control samples at 500 ng/ml of (R,S)-methadone. Trueness values were 106.6% and 103.0% for (R)-MTD and (S)-MTD, respectively, with a coefficient of variation inferior to 2.5% for both compounds. Finally, a good concordance was found using this method for analysis of plasma samples from patients in maintenance treatment as compared to a previously described HPLC-UV method after liquid-liquid extraction. 相似文献
59.
60.